Vasospasm-induced myocardial infarction with sumatriptan

Headache

Volumn 36, Issue 5, 1996, Pages 329-331

  Mueller, Loretta ^a   Gallagher, R Michael ^a   Ciervo, Carman A ^a  

^a University Headache Center   (United States)

Author keywords

migraine; myocardial infarction; sumatriptan; vasospasm

Indexed keywords

SUMATRIPTAN;

ADULT; ARTICLE; CASE REPORT; CORONARY ARTERY SPASM; DRUG EFFECT; ELECTROCARDIOGRAM; FEMALE; HEART CATHETERIZATION; HEART INFARCTION; HUMAN; MIGRAINE; PRIORITY JOURNAL; THORAX PAIN;

CORONARY VASOSPASM; FEMALE; HUMANS; INJECTIONS, SUBCUTANEOUS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; MYOCARDIAL INFARCTION; SEROTONIN AGONISTS; SUMATRIPTAN; VASOCONSTRICTOR AGENTS;

EID: 0030013567     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-4610.1996.3605329.x     Document Type: Article

References (19)

1. The Subcutaneous Sumatriptan International Study Group. Treatment of migraine attacks with sumatriptan. N Engl J Med. 1991;325:316-321.
2. Cady RK, Wendt JK, Kirchner JR, Sargent JD, Rothrock JF, Skaggs H Jr. Treatment of acute migraine with subcutaneous sumatriptan. JAMA. 1991;265:2831-2835.
3. Product information for Imitrex® Injection.
4. MacIntyre PD, Bhargava B, Hogg KJ, Gemmill JD, Hillis WS. Effect of subcutaneous sumatriptan, a selective 5HT1 agonist, on the systemic, pulmonary, and coronary circulation. Circulation. 1993;87:401-405.
5. Connor HE, Feniuk W, Humphrey PP. 5-Hydroxytryptamine contracts human coronary arteries predominantly via 5-HT2 receptor activation. Eur J Pharmacol. 1989;161:91-94.
6. Kaumann AJ, Frenken M, Posival H, Brown AM. Variable participation of 5-HT1- like receptors and 5-HT2 receptors in serotonin-induced contraction of human isolated coronary arteries. 5-HT1-like receptors resemble cloned 5-HT1D beta receptors. Circulation. 1994;90:1141-1153.
7. Golino P, Maseri A. Serotonin receptors in human coronary arteries. Circulation. 1994;90:1573-1575.
8. MacIntyre PD, Bhargava B, Hogg KJ, Gemmill JD, Hillis WS. The effect of i.v. sumatriptan, a selective 5-HT1-receptor agonist on central haemodynamics and the coronary circulation. Br J Pharmacol. 1992;34:541-546.
9. Willett F, Curzen N, Adams J, Armitage M. Coronary vasospasm induced by subcutaneous sumatriptan. BMJ. 1992;304:1415.
10. Castle WM, Simmons VE. Coronary vasospasm and sumatriptan. BMJ. 1992;305:117-118.
11. Lloyd DK, Pilgrim AJ, Simmons VE. Coronary vasospasm and sumatriptan. BMJ. 1992;305:310-311.
12. Stricker BH. Coronary vasospasm and sumatriptan. BMJ. 1992;305:118.
13. Ottervanger JP, Paalman HJ, Boxma GL, Stricker BH. Transmural myocardial infarction with sumatriptan. Lancet. 1993;341:861-862.
14. Curtin T, Brooks AP, Roberts JA. Cardiorespiratory distress after sumatriptan given by injection. BMJ. 1992;305:713-714.
15. Inman W, Kubota K. Cardiorespiratory distress after sumatriptan given by injection. BMJ. 1992;305:714.
16. Ottervanger JP, van Witsen TB, Valkenburg HA, Stricker BH. Postmarketing study of cardiovascular adverse reactions associated with sumatriptan. BMJ. 1993;307:1185.
17. Abrahamsen B, Christiansen BD. Angina pectoris after sumatriptan (Imigran). Ugeskr Laeger, 1992;154:3602-3603.
18. Brown EG, Endersby CA, Smith RN, Talbot JC. The safety and tolerability of sumatriptan: an overview. Eur Neurol. 1991;31:339-344.
19. Ottervanger JP, van Witsen TB, Valkenburg HA, Grobbee DE, Stricker BH. Adverse reactions attributed to sumatriptan. A postmarketing study in general practice. Eur J Clin Pharmacol. 1994;47:305-309.